Parainfluenza virus vaccine - St. Jude Children's Research Hospital

Drug Profile

Parainfluenza virus vaccine - St. Jude Children's Research Hospital

Alternative Names: hPIV-1 vaccine - St Jude Children's Research Hospital

Latest Information Update: 20 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator St. Jude Childrens Research Hospital
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Suspended Parainfluenza virus infections

Most Recent Events

  • 02 Feb 2005 Clinical data from a media release have been added to the adverse events and Viral infections immunogenicity sections
  • 25 Aug 2004 Phase-I clinical trials in Parainfluenza virus infections in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top